FourThought Financial’s Exact Sciences EXAS Stock Holding History

FourThought Financial’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$78K	Buy	2,400 +1,185	+98%	+$48.9K	0.01%	491
2022 Q2	$48K	Sell	1,215 -152	-11%	-$8.13K	0.01%	616
2022 Q1	$96K	Sell	1,367 -62	-4%	-$4.53K	0.01%	485
2021 Q4	$111K	Sell	1,429 -1,577	-52%	-$139K	0.01%	456
2021 Q3	$286K	Sell	3,006 -1,350	-31%	-$143K	0.04%	281
2021 Q2	$541K	Sell	4,356 -977	-18%	-$117K	0.07%	198
2021 Q1	$702K	Buy	5,333 +260	+5%	+$35.6K	0.1%	152
2020 Q4	$672K	Buy	+5,073	New	+$613K	0.11%	151

Other funds holding EXAS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

FourThought Financial's EXAS Position: Q3 2022 in Review

FourThought Financial increased its Exact Sciences (EXAS) stake by 98% in Q3 2022, buying an estimated $48.9K and bringing the position to 2,400 shares worth $78K. The position accounts for 0.01% of the portfolio, ranked #491.

FourThought Financial first reported a position in EXAS in Q4 2020 and has held it in 8 quarters since. The position peaked at $702K in Q1 2021. 480 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

FourThought Financial held 2,400 shares of Exact Sciences worth $78K as of Q3 2022.
FourThought Financial bought 1,185 Exact Sciences shares in Q3 2022, an estimated $48.9K.
Exact Sciences made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #491 holding.
FourThought Financial first reported a position in Exact Sciences in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Exact Sciences position peaked at $702K in Q1 2021.
480 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.